Verónica Mireya Rodríguez

Verónica Mireya Rodríguez

Auto-generated profile, based on publicly available information

Verónica Mireya Rodríguez

Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Toxicology Letters
Verified
Journal Article
Closed access
VRV M Rodríguez
V M Rodríguez
MCMaria Jimenez Capdeville
Maria Jimenez Capdeville
MNMaria Magdalena Giordano Noyola
Maria Magdalena Giordano Noyola

1 September 2009 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
UBU. Bardullas
U. Bardullas
JLJ.H. Limón-Pacheco
J.H. Limón-Pacheco
MNMaria Magdalena Giordano Noyola
Maria Magdalena Giordano Noyola
LCL. Carrizales
L. Carrizales
MMM.S. Mendoza-Trejo
M.S. Mendoza-Trejo
VRV.M. Rodríguez
V.M. Rodríguez

15 December 2004 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
VRV. M. Rodriguez
V. M. Rodriguez
Inorganic arsenic exposure via drinking water has been associated with cancer and serious injury in various internal organs, as well as with peripheral neuropathy and diverse effects in the nervous system. Alterations in memory and attention processes have been reported in exposed children, whereas adults acutely exposed to high amounts of inorganic arsenic showed impairments in learning, memory, and concentration. Glutathione (GSH) is extensively involved in the metabolism of inorganic arsenic, and both arsenite and its methylated metabolites have been shown to be potent inhibitors of glutathione reductase (GR) in vitro. Brain would be more susceptible to GR inhibition because of the decreased activities of superoxide dismutase (SOD) and catalase reported in this tissue. To investigate whether GR inhibition could be documented in vivo, we determined the activity and levels of GR in brain as well as in liver, the main organ of arsenic metabolism in mice exposed to 2.5, 5, or 10 mg/kg/day of sodium arsenite over a period of 9 days. In contrast to what has been observed in vitro, significant inhibition of the expression and activity of GR was observed only at the highest concentration used (10 mg/kg/day) in both organs. Although the disposition of arsenicals was higher in liver, significant amounts of inorganic and methylated arsenic forms were determined in the brain of exposed animals. The formation of monomethylarsenic (MMA) and dimethylarsenic (DMA) metabolites in the brain was confirmed by incubating brain slices for 24, 48, and 72 h with sodium arsenite.


1 January 2015 in NeuroToxicology
Verified
Journal Article
Closed access
IHIsela Hernández-Plata
Isela Hernández-Plata
MNMaria Magdalena Giordano Noyola
Maria Magdalena Giordano Noyola
MDMauricio Díaz-Muñoz
Mauricio Díaz-Muñoz
VRVerónica M. Rodríguez
Verónica M. Rodríguez

1 November 2010 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
VRVerónica Mireya Rodríguez
Verónica Mireya Rodríguez
JLJorge Humberto Limón-Pacheco
Jorge Humberto Limón-Pacheco
LCLeticia Carrizales
Leticia Carrizales
MMMaría Soledad Mendoza-Trejo
María Soledad Mendoza-Trejo
MNMaria Magdalena Giordano Noyola
Maria Magdalena Giordano Noyola